Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
220.80
|
|
Change (%)
|
-4.00 (-1.78%)
|
|
Best Buy (RS)
|
220.65(x28)
|
|
Best Sell (RS)
|
221.2(x44)
|
|
Today's Range (RS)
|
220.35
-
224.95
|
|
52-Week Range (RS)
|
217.35
-
464.50
|
|
Beta (1 Year)
|
0.80
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Hikal receives revision in credit ratings from ICRA |
| Hikal reports consolidated net loss of Rs 34.90 crore in the September 2025 quarter |
| Hikal Ltd - Hikal Limited - Updates |
| Hikal to hold board meeting |
| Hikal Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| Hikal Ltd - Hikal Limited - Updates |
| Hikal Ltd - Hikal Limited - Updates |
| Hikal Ltd - Hikal Limited - Updates |
| Hikal Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Hikal Ltd - Change Of Email Address Of The Registrar And Share Transfer Agent (RTA) Of The Company |
|
|
|
| Incoporation Year : 1988 |
| Chairman : J Hiremath |
| Ownership Group : Kalyani |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs |
| Registered Office |
Hikal Ltd
717/718 Maker Chamber V,
7th Floor Nariman Point,
Mumbai,
Maharashtra-400021 |
Phone:91-022-3926 7100/62770477
Fax:91-022-2283 3913 |
| E-Mail : info@hikal.com |
| URL : http://www.hikal.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
18-Nov-2025 |
229.00 |
-1.83 |
| 1Month |
27-Oct-2025 |
242.00 |
-7.11 |
| 3Month |
25-Aug-2025 |
256.30 |
-12.29 |
| 6Month |
26-May-2025 |
378.85 |
-40.66 |
| 1Year |
25-Nov-2024 |
396.05 |
-43.24 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Tata Small Cap Fund |
0.67 |
78.66 |
| ICICI Pru P.H.D Fund |
0.84 |
54.22 |
| Tata India Pharma & Healthcare Fund |
0.71 |
9.39 |
| Motilal Oswal Nifty Microcap 250 Index.. |
0.11 |
3.05 |
| Motilal Oswal BSE Healthcare ETF |
0.06 |
0.02 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Divis Laboratories Ltd |
6,492.65 |
1.21 |
7,077.70 |
4,941.70 |
170,299.42 |
| Neuland Laboratories Ltd |
16,646.40 |
-1.31 |
19,748.40 |
10,060.00 |
21,639.72 |
| Jubilant Pharmova Ltd |
1,104.40 |
1.61 |
1,263.90 |
823.70 |
17,315.11 |
| Acutaas Chemicals Ltd |
1,772.50 |
-0.57 |
1,901.35 |
919.63 |
14,595.16 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) |
301.05 |
0.00 |
0.00 |
0.00 |
4,858.77 |
|
|
|
|